
Elysium Venture Fund

Life sciences venture firm investing in early-stage treatments and diagnostics for rare diseases

Chiesi Ventures is a life sciences venture capital firm dedicated to rare and orphan disorders. It complements the strategic interests of the Chiesi Group by investing in early-stage development opportunities.
Companies developing treatments for rare diseases. In September 2014 it announced a collaboration with Pappas Capital to help find and assess deals, lead investments and manage transactions.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-08. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Chiesi Ventures.
Similar listings buyers compare against this one.

Elysium Venture Fund

Venture firm investing in software and hardware startups for architecture, engineering and construction

StarLaunch is a launchpad and incubator for blockchain projects, mainly on the Solana network

Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions

Commodity intelligence platform giving food and beverage buyers price data and forecasts

Seed-stage venture capital firm backing technology and consumer packaged goods startups with a sustainability focus
Everything here links back to the same verified catalogue. Pick your next stop.